Pantera a United States blockchain investment firm was quoted saying that almost 25% of its funds that were previously invested in digital assets or projects that may have gone against the United States securities regulations. This highlights a rather growing concern in the cryptocurrency business about the digital tokens that were issued in the past two years. Some of these companies may have also violated U.S. securities laws.
SEC’s stand on its laws
The California based cryptocurrency company, Pantera is one of the largest digital currency investors. A monthly letter sent to subscribers and clients, the chief executive of the investment firm Joey Krug said The non compliant investment projects are likely to end up putting an up an offer to buy back the tokens at the same sale price from the investors and will ultimately have to register as securities as required by the law. The company did not give any further comments.
In November, SEC announced that it had settled its charges against non compliant coin offerings. SEC concluded by saying that all tokens are deemed securities and if they are sold to any United States non accredited investors without looking up to an exemption, they will be considered non compliant.
Most of the Pantera’s digital currency investments will not be affected
Between the end of the last year and the beginning of this year, several initial coin offerings were released to the public market. This led to the growth of a number of projects. Some of these projects were able to raise millions of dollars in investment funds from all across the globe. However, most of these funds have been used up by the market since virtual currencies fell to new lows last year.
The co-chief investment officers recently commented on how the SEC laws would ultimately affect their business and investors. They were quoted saying; “While we believe a large majority of our projects will not be affected, approximately a quarter of our fund’s in capital is invested in projects with tokens that were sold to investors in the United States contrary to using regulation D or S.”
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:
The Next Big Thing In Biotech?https://journaltranscript.com
Get our top rated alerts on the biotech sector
Miner Stock About To Explodehttps://www.journaltranscript.com
Investors are flocking to this stock like no tomorrow !
Traders Need To Know This Nowhttps://journaltranscript.com
WallStreet is loading up on this stock. Find out why